Grand Brilliance Group Holdings Ltd is an investment holding company primarily engaged in the supply of medical devices. The Company also provides medical device solutions, including market trend analysis, medical device procurement, after-sales service, technical support and training, medical device rental services, and quality assurance. The Company primarily sells medical device products, including medical consumables, medical equipment, and medical devices. In addition, the Company also offers repair services and medical device rental services.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
11/09/26	HK$0.1470	0.00%	0
10/09/26	HK$0.1470	-4.55%	360,000
09/09/26	HK$0.1540	0.00%	0
08/09/26	HK$0.1540	0.00%	0
07/09/26	HK$0.1540	-1.28%	200,000

Delayed Quote Hong Kong S.E.

More quotes

Market Closed - Hong Kong S.E. 09:08:55 11/09/2026 BST			5-day change	1st Jan Change
0.1470 ^HKD	0.00%		-5.77%	+12.21%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI

Market Cap	118M 14.99M 12.92M 12.23M 11.09M 20.8M 1.43B 20.91M 145M 55.87M 729M 56.31M 55.08M 2.3B	P/E 2025	9.13x	P/E 2026	12.5x
Enterprise Value	62.25M 7.94M 6.84M 6.48M 5.87M 11.01M 758M 11.07M 76.9M 29.57M 386M 29.81M 29.15M 1.22B	EV / Sales 2025	0.25x	EV / Sales 2026	0.49x
Free-Float	26.93%	Yield 2025	2.31%	Yield 2026	1.91%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
11-21	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Announces Interim Dividend for the Financial Year End 31 March 2025, Payable on August 11, 2025	CI
27/05/25	Grand Brilliance Group Holdings Limited Announces Board and Committee Changes, Effective 1 June 2025	CI
14/03/25	Grand Brilliance Group Holdings Limited Announces Resignation of Mr. Mui Wai Sum as Independent Non-Executive Director and Chairman and Member of the Audit Committee and Member of Remuneration Committee	CI
08/11/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Declares Interim Dividend for the Year Ended 31 March 2024, Payable on or Before 12 August 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
13/11/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
15/09/23	Grand Brilliance Group Holdings Limited Announces Board Changes, Effective September 18, 2023	CI
11/08/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI

1 week	-5.77%
Current month	+0.68%
1 month	+10.53%
3 months	-2.00%
6 months	+13.08%
Current year	+12.21%

Grand Brilliance Group Holdings Limited Share Price

Stocks

8372

KYG4136R1020

Medical Equipment, Supplies & Distribution

Valuation : Grand Brilliance Group Holdings Limited

Chart: Grand Brilliance Group Holdings Limited

Latest news : Grand Brilliance Group Holdings Limited

Quotes and Performance

Price Extremes

Managers and Directors : Grand Brilliance Group Holdings Limited

Medical Equipment Wholesale

Financials

Company Profile

Quotes

1 week	0.14	0.15
1 month	0.13	0.16
Current year	0.12	0.18
1 year	0.1	0.18
3 years	0.07	0.18
5 years	0.06	0.18
10 years	0.06	0.57

Manager	Title	Age	Since
Bik Kwan Wong CEO	Chief Executive Officer	57	28/02/2018
Chong Chi Cheung DFI	Director of Finance/CFO	48	-
Ka Man Lee SEC	Corporate Secretary	52	23/09/2019

Director	Title	Age	Since
Bik Kwan Wong CHM	Chairman	57	28/02/2018
Yin Shun Miu BRD	Director/Board Member	59	17/09/2017
Man Wai Chiu BRD	Director/Board Member	57	17/09/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GRAND BRILLIANCE GROUP HOLDINGS LIMITED	0.00%	-5.77%	+32.43%	+107.04%	14.99M
HENRY SCHEIN, INC.	+1.21%	-1.61%	+27.05%	+18.96%	9.85B
SHIP HEALTHCARE HOLDINGS, INC.	+1.49%	+0.29%	+4.12%	+1.89%	1.43B
SHANGHAI C&D INNOSTIC MEDICAL TECHNOLOGY GROUP CO., LTD.	-3.32%	-6.25%	-	-	1.23B
AS ONE CORPORATION	-0.02%	-2.15%	-4.29%	-14.78%	1.14B
COWEALTH MEDICAL CHINA CO.,LTD.	-5.19%	-9.66%	+81.21%	+44.80%	727M
GKHT MEDICAL TECHNOLOGY CO., LTD.	-2.57%	-4.03%	-27.29%	-56.70%	581M
EXCELSIOR MEDICAL CO., LTD.	-0.27%	+2.40%	-15.68%	-9.46%	432M
NIPPON CARE SUPPLY CO., LTD.	-0.23%	+0.47%	+96.31%	+150.00%	431M
PT MULTI MEDIKA INTERNASIONAL TBK	+1.80%	+6.25%	+338.14%	+771.79%	232M
Average	-0.71%	-2.35%	+59.11%	+112.62%	1.61B
Weighted average by Cap.	+0.30%	-2.17%	+28.59%	+27.86%

	2025	2026
Net sales	94.45M 12.04M 10.38M 9.82M 8.9M 16.71M 1.15B 16.79M 117M 44.87M 585M 45.23M 44.23M 1.85B	101M 12.84M 11.06M 10.48M 9.5M 17.81M 1.23B 17.9M 124M 47.85M 624M 48.23M 47.17M 1.97B
Net income	9.46M 1.21M 1.04M 984K 892K 1.67M 115M 1.68M 11.69M 4.49M 58.63M 4.53M 4.43M 185M	8.41M 1.07M 924K 875K 793K 1.49M 102M 1.5M 10.39M 4M 52.14M 4.03M 3.94M 165M
Net Debt	-62.36M -7.95M -6.85M -6.49M -5.88M -11.03M -760M -11.09M -77.05M -29.63M -386M -29.86M -29.21M -1.22B	-55.35M -7.06M -6.08M -5.76M -5.22M -9.79M -674M -9.84M -68.38M -26.3M -343M -26.51M -25.92M -1.08B